GMED

(GMED)

Financial Statements · SEC EDGAR XBRL

Revenue

$2.94B

+16.7%

Net Income

$537.9M

+422.3%

EPS

$3.92

+422.7%

Gross Margin

67.4%

Op. Income

$479.8M

+189.1%

FCF

$588.8M

+45.3%

Source: SEC EDGAR XBRL

Breakdown

Revenues

Total Revenues

Cost of Revenues

Gross Profit

Operating Expenses & Income

Operating Income

Non-Operating Income/Expense

Net Income

EPS (Basic)

EPS (Diluted)

FY 2025

FY 2024

FY 2023

FY 2022

$2.94B

$2.52B

$1.57B

$1.02B

$2.94B

$2.52B

$1.57B

$1.02B

$957.8M

$1.04B

$548.2M

$263.7M

$1.98B

$1.48B

$1.02B

$759.1M

$479.8M

$166.0M

$133.1M

$228.0M

$537.9M

$103.0M

$122.9M

$190.2M

$3.98

$0.76

$1.09

$1.89

$3.92

$0.75

$1.07

$1.85